Neuroscience
Multiple Sclerosis
100%
Alzheimer's Disease
100%
Brain Lesion
80%
Neurodegeneration
61%
Primary Progressive Multiple Sclerosis
50%
Gray Matter
50%
Magnetic Resonance Imaging
50%
Cyclin Dependent Kinase 5
50%
Synapse Formation
50%
Demyelinating Disease
50%
Proteomics
50%
Sterol
50%
Gelsolin
50%
Sphingolipid
50%
Clinically Isolated Syndrome
50%
Cell Function
50%
Nerve Cell Membrane
50%
Blood Plasma
50%
Magnetic Resonance Imaging
38%
Magnetization Transfer
25%
Expanded Disability Status Scale
25%
Optic Radiation
16%
Corpus Callosum
14%
Spatial Memory
11%
Western Blot
11%
Superior Longitudinal Fasciculus
10%
Corona Radiata
8%
Clinical Assessment
8%
Secondary Progressive Multiple Sclerosis
8%
Internal Capsule
8%
Splenium
8%
Gray Matter Volume
6%
Neurotoxicity
5%
Synaptic Plasticity
5%
Vertebral Column
5%
Mass Spectrometry
5%
Septin
5%
Magnetic Resonance Imaging of Brain
5%
Blood Protein
5%
Neurodegenerative Disorder
5%
Beta Amyloid
5%
Mental Status Examination
5%
Biochemistry, Genetics and Molecular Biology
Small Interfering RNA
50%
Polo-Like Kinase 1
50%
14-3-3 Protein
50%
Gelsolin
50%
G Protein
50%
Primary Cell
50%
Magnetic Resonance Imaging
50%
Nerve Cell Culture
50%
Messenger RNA
50%
Guanosine Triphosphate
50%
Tandem Mass Spectrometry
50%
Quantitative Proteomics
50%
Blood Plasma
50%
Protein Content
33%
Proteomics
33%
Clinical Trial
25%
Gene Expression Profiling
25%
Small Molecule
25%
Oncogene
25%
Programmed Cell Death
25%
Tumor Volume
25%
Keratinocyte
25%
Carcinogenesis
25%
Tumor Progression
25%
Crystal Structure
16%
Coiled Coil
16%
Rnd1
16%
Rho Factor
16%
Ras Superfamily
16%
C-Terminus
16%
Centrifugation
16%
Synapse
16%
Cell Membrane
16%
Sphingolipid
16%
Binding Site
16%
Protein Kinase
16%
Sterol
16%
Nerve Cell Membrane
16%
Cell Function
16%
calcium activated,phospholipid dependent protein kinase
16%
Lysine
16%
Liquid Chromatography-Mass Spectrometry
16%
Isobaric Labeling
8%
Tandem Mass Tag
8%
Blood Protein
6%
Serum Total Protein
6%
Amyloid Beta
6%
Multivariate Analysis
6%
Western Blot
6%
Mental Health
6%
Medicine and Dentistry
Multiple Sclerosis
100%
Magnetic Resonance Imaging
88%
Cerebral Atrophy
55%
Clinically Isolated Syndrome
50%
Polo Like Kinase 1
50%
Skin Carcinoma
50%
Messenger RNA
50%
Expanded Disability Status Scale
25%
Cancer
21%
In Vitro
14%
Small Interfering RNA
14%
Combination Therapy
12%
Disease Exacerbation
12%
Reproducibility
12%
Spinal Cord Atrophy
12%
Corpus Callosum
8%
Multiple Linear Regression Analysis
8%
Internal Capsule
8%
Student T Test
8%
Splenium
8%
Clinical Assessment
8%
Cancer Therapy
7%
Skin Tumor
7%
Tumor Progression
7%
Tumour Heterogeneity
7%
Psoriasis
7%
Malignant Neoplasm
7%
Clinical Trial
7%
Keratinocyte
7%
Carcinogenesis
7%
Programmed Cell Death
7%
Gene Expression Profiling
7%
Tumor Xenograft
7%
Magnetic Resonance Imaging of Brain
5%
Clinical Stage
5%
Diseases
5%
